GlassScriptPhysician profile
Fatima Qureshi
NPI 1477894327
$5,019.91
in general payments reported to CMS, 2019-2025
18 companies · $61.93 in 2025
The $61.93 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,649 · 2020: $238 · 2021: $882 · 2022: $1,325 · 2023: $613 · 2024: $252 · 2025: $61.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871 · Entertainment: $55.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $871.41 |
| Entertainment | $55.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,235.60 | 2019-2023 | Dailies Total1, Rocklatan, Hydrus Microstent |
| Johnson & Johnson Surgical Vision, INC. | $866.84 | 2022 | |
| Allergan, INC. | $399.37 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $393.62 | 2021-2022 | |
| Glaukos Corporation | $373.35 | 2021-2025 | Ce-Marked Kxla System, Photrexa Viscous and Photrexa |
| Sun Pharmaceutical Industries INC. | $345.50 | 2019-2023 | Cequa |
| Oyster Point Pharma, INC. | $264.13 | 2022-2024 | Tyrvaya, Ryzumvi |
| Biotissue Holdings INC. | $264.06 | 2020-2024 | |
| Optos, INC. | $202.70 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $176.79 | 2021 | |
| Bausch & Lomb Americas INC. | $162.84 | 2023-2025 | Infuse |
| Ocular Therapeutix, INC. | $117.18 | 2020 | |
| Rxsight INC | $74.68 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Abbvie INC. | $41.63 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $34.18 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $32.28 | 2020-2021 | |
| Sight Sciences, INC. | $18.95 | 2024 | Tearcare System |
| Coopervision INC. | $16.21 | 2024 | Clariti Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fatima Qureshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.